X4 Pharmaceuticals Statistics
Total Valuation
XFOR has a market cap or net worth of $318.59 million. The enterprise value is $208.09 million.
| Market Cap | 318.59M |
| Enterprise Value | 208.09M |
Important Dates
The last earnings date was Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XFOR has 102.11 million shares outstanding. The number of shares has increased by 660.42% in one year.
| Current Share Class | 102.11M |
| Shares Outstanding | 102.11M |
| Shares Change (YoY) | +660.42% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 61.87% |
| Float | 60.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.78 |
| Forward PS | 29.69 |
| PB Ratio | 2.27 |
| P/TBV Ratio | 2.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.22, with a Debt / Equity ratio of 0.56.
| Current Ratio | 13.22 |
| Quick Ratio | 12.62 |
| Debt / Equity | 0.56 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.43 |
Financial Efficiency
Return on equity (ROE) is -80.32% and return on invested capital (ROIC) is -275.59%.
| Return on Equity (ROE) | -80.32% |
| Return on Assets (ROA) | -23.13% |
| Return on Invested Capital (ROIC) | -275.59% |
| Return on Capital Employed (ROCE) | -33.74% |
| Weighted Average Cost of Capital (WACC) | 7.23% |
| Revenue Per Employee | $376,911 |
| Profits Per Employee | -$1.79M |
| Employee Count | 45 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 0.65 |
Taxes
In the past 12 months, XFOR has paid $5,000 in taxes.
| Income Tax | 5,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.38% in the last 52 weeks. The beta is 0.47, so XFOR's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -19.38% |
| 50-Day Moving Average | 3.15 |
| 200-Day Moving Average | 3.78 |
| Relative Strength Index (RSI) | 47.77 |
| Average Volume (20 Days) | 741,051 |
Short Selling Information
The latest short interest is 7.97 million, so 7.81% of the outstanding shares have been sold short.
| Short Interest | 7.97M |
| Short Previous Month | 7.49M |
| Short % of Shares Out | 7.81% |
| Short % of Float | 13.24% |
| Short Ratio (days to cover) | 11.05 |
Income Statement
In the last 12 months, XFOR had revenue of $16.96 million and -$80.52 million in losses. Loss per share was -$0.66.
| Revenue | 16.96M |
| Gross Profit | 13.87M |
| Operating Income | -73.15M |
| Pretax Income | -80.52M |
| Net Income | -80.52M |
| EBITDA | -71.38M |
| EBIT | -73.15M |
| Loss Per Share | -$0.66 |
Balance Sheet
The company has $187.70 million in cash and $77.20 million in debt, with a net cash position of $110.51 million or $1.08 per share.
| Cash & Cash Equivalents | 187.70M |
| Total Debt | 77.20M |
| Net Cash | 110.51M |
| Net Cash Per Share | $1.08 |
| Equity (Book Value) | 138.88M |
| Book Value Per Share | 1.38 |
| Working Capital | 183.15M |
Cash Flow
| Operating Cash Flow | -76.10M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.77M |
| Net Borrowing | n/a |
| Free Cash Flow | -76.10M |
| FCF Per Share | -$0.75 |
Margins
| Gross Margin | 81.77% |
| Operating Margin | -431.30% |
| Pretax Margin | -474.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
XFOR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -660.42% |
| Shareholder Yield | -660.42% |
| Earnings Yield | -21.05% |
| FCF Yield | -23.89% |
Analyst Forecast
The average price target for XFOR is $11.60, which is 271.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.60 |
| Price Target Difference | 271.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 1.16% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on April 28, 2025. It was a reverse split with a ratio of 1:30.
| Last Split Date | Apr 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
XFOR has an Altman Z-Score of -1.78 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.78 |
| Piotroski F-Score | 2 |